| Richard L Taikowski, MD | |
|
1305 Post Rd, Fairfield, CT 06824-6016 | |
| (203) 292-2000 | |
| (203) 292-0832 |
| Full Name | Richard L Taikowski |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 1305 Post Rd, Fairfield, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649275462 | NPI | - | NPPES |
| 001314153 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 031415 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
| Bridgeport Hospital | 2062312598 | 93 |
News Archive
A new study by NYU Medical Center researchers shows for the first time that the immune system can combat the pathological form of tau protein, a key protein implicated in Alzheimer's disease.
"Health efforts are close to wiping out polio, but two significant challenges remain: money and the operational logistics of getting the vaccine to people who need it," CNN writes in an article examining "how far we've come with polio and what's left to be done."
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare's Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.
› Verified 8 days ago
| Entity Name | Bridgeport Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649260845 PECOS PAC ID: 2062312598 Enrollment ID: O20040120000425 |
News Archive
A new study by NYU Medical Center researchers shows for the first time that the immune system can combat the pathological form of tau protein, a key protein implicated in Alzheimer's disease.
"Health efforts are close to wiping out polio, but two significant challenges remain: money and the operational logistics of getting the vaccine to people who need it," CNN writes in an article examining "how far we've come with polio and what's left to be done."
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare's Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.
› Verified 8 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
A new study by NYU Medical Center researchers shows for the first time that the immune system can combat the pathological form of tau protein, a key protein implicated in Alzheimer's disease.
"Health efforts are close to wiping out polio, but two significant challenges remain: money and the operational logistics of getting the vaccine to people who need it," CNN writes in an article examining "how far we've come with polio and what's left to be done."
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare's Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard L Taikowski, MD 1305 Post Rd, Fairfield, CT 06824-6016 Ph: (203) 292-2000 | Richard L Taikowski, MD 1305 Post Rd, Fairfield, CT 06824-6016 Ph: (203) 292-2000 |
News Archive
A new study by NYU Medical Center researchers shows for the first time that the immune system can combat the pathological form of tau protein, a key protein implicated in Alzheimer's disease.
"Health efforts are close to wiping out polio, but two significant challenges remain: money and the operational logistics of getting the vaccine to people who need it," CNN writes in an article examining "how far we've come with polio and what's left to be done."
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare's Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.
› Verified 8 days ago
Dr. Igal Staw, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 Post Rd, Ste 202, Fairfield, CT 06824 Phone: 203-853-1919 Fax: 203-855-9002 | |
Dr. Fereshteh Ahmadian, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 111 Beach Rd, Ste 3, Fairfield, CT 06824 Phone: 203-255-2340 | |
Mr. Adrian Dafcik, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 134 Round Hill Road, Fairfield, CT 06824 Phone: 203-255-0695 Fax: 203-255-0629 | |
Ana Patricia Echeverri, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Beach Rd Ste 3, Fairfield, CT 06824 Phone: 203-255-2340 Fax: 203-255-0619 | |
Dr. Peter R Cimino, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1300 Post Rd, Suite 202, Fairfield, CT 06824 Phone: 203-255-8827 Fax: 203-259-4610 | |
Dr. Kenneth C Fine, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 175 Jefferson St, Fairfield, CT 06825 Phone: 203-365-6473 Fax: 203-396-1039 | |
Dr. Slava I Kulakov, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 134 Round Hill Rd, Fairfield, CT 06824 Phone: 203-255-0695 Fax: 203-255-0629 |